In this context, Jean PERRIN Centre has initiated a prospective interventional study in order to study the feasibility of a home-based physical activity intervention among HER2-positive breast cancer patients currently treated with neoadjuvant chemotherapy + targeted therapy. The gene discussed is ERBB2; the disease is breast carcinoma.